Five-year results of verteporfin photodynamic therapy in pathologic myopia: Third year of an open-label extension of the VIP Trial

被引:0
|
作者
Soubrane, G [1 ]
机构
[1] Eye Univ Clin Creteil, Dept Ophthalmol, Creteil, France
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2277
引用
收藏
页码:U904 / U904
页数:1
相关论文
共 50 条
  • [1] Five-year results of verteporfin therapy for subfoveal CNV due to AMD: Third year of an open-label extension of the TAP investigation
    Kaiser, PK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U297 - U297
  • [2] Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
    Gillies, Mark C.
    Simpson, Judy M.
    Gaston, Christine
    Hunt, Grace
    Ali, Haipha
    Zhu, Meidong
    Sutter, Florian
    OPHTHALMOLOGY, 2009, 116 (11) : 2182 - 2187
  • [3] Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin -: 1-year results of a randomized clinical trial -: VIP report no. 1
    Arnold, J
    Kilmartin, D
    Olson, J
    Neville, S
    Robinson, K
    Laird, A
    Richmond, C
    Farrow, A
    McKay, S
    Saperstein, DA
    Aaberg, TM
    Johnson, JB
    Waldron, R
    Loupe, D
    Gillman, J
    Myles, B
    Schachat, AP
    Bressler, NM
    Bressler, SB
    Nesbitt, P
    Porter, T
    Hawse, P
    Hartnett, M
    Eager, A
    Belt, J
    Cain, D
    Emmert, D
    George, T
    Herring, M
    McDonald, J
    Monés, J
    Corcóstegui, B
    Gilbert, M
    Duran, N
    Sisquella, M
    Nolla, A
    Margalef, A
    Miller, JW
    Gragoudas, ES
    Lane, AM
    Emmanuel, N
    Holbrook, A
    Evans, C
    Lord, US
    Walsh, DK
    Callahan, CD
    DuBois, JL
    Lewis, H
    Kaiser, PK
    Holody, LJ
    OPHTHALMOLOGY, 2001, 108 (05) : 841 - 852
  • [4] Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in pathologic myopia using verteporfin: Two-year results - VIP report #4.
    Lim, JI
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S304 - S304
  • [5] Photodynamic therapy with verteporfin in ocular histoplasmosis: Uncontrolled, open-label 2-year study
    Rosenfeld, PJ
    Saperstein, DA
    Bressler, NM
    Reaves, TA
    Sickenberg, M
    Rosa, RH
    Sternberg, P
    Aaberg, TM
    Aaberg, TM
    OPHTHALMOLOGY, 2004, 111 (09) : 1725 - 1733
  • [6] Photodynamic Therapy with Verteporfin for Symptomatic Circumscribed Choroidal Hemangioma: Five-Year Outcomes
    Blasi, Maria Antonietta
    Tiberti, Alessandra C.
    Scupola, Andrea
    Balestrazzi, Angelo
    Colangelo, Egle
    Valente, Paola
    Balestrazzi, Emilio
    OPHTHALMOLOGY, 2010, 117 (08) : 1630 - 1637
  • [7] Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia - 2-year results of a randomized clinical Trial - VIP report no. 3
    Blinder, KJ
    Blumenkranz, MS
    Bressler, NM
    Bressler, SB
    Donati, G
    Lewis, H
    Lim, JI
    Menchini, U
    Miller, JW
    Mones, JM
    Potter, MJ
    Pournaras, C
    Reaves, A
    Rosenfeld, P
    Schachat, AP
    Schmidt-Erfurth, U
    Sickenberg, M
    Singerman, LJ
    Slakter, J
    Strong, HA
    Virgili, G
    Williams, GA
    OPHTHALMOLOGY, 2003, 110 (04) : 667 - 673
  • [8] Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia - 1-year results of a prospective series
    Lam, DSC
    Liu, DTL
    Fan, DSP
    Lai, WW
    So, SF
    Chan, WM
    EYE, 2005, 19 (08) : 834 - 840
  • [9] Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia—1-year results of a prospective series
    D S C Lam
    D T L Liu
    D S P Fan
    W W Lai
    S F So
    W-M Chan
    Eye, 2005, 19 : 834 - 840
  • [10] Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
    Tsuchihashi, Takashi
    Mori, Keisuke
    Ueyama, Kazuhiro
    Yoneya, Shin
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 615 - 620